US Food and Drug Administration defends use of placebo-controlled trials

被引：4
|
作者：
Larkin, M
机构：
来源：
LANCET | 2000年 / 356卷 / 9235期
关键词：
D O I：
10.1016/S0140-6736(05)74530-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1086 / 1086
页数：1
相关论文
共 50 条
  • [31] Building in placebo-controlled trials - In response
    Desbiens, NA
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) : 1151 - 1151
  • [32] Placebo-controlled clinical trials: A reappraisal
    Bouvenot, G
    REVUE DU RHUMATISME, 1996, 63 (09): : 565 - 567
  • [33] Placebo-controlled trials: when are they needed?
    Streiner, DL
    SCHIZOPHRENIA RESEARCH, 1999, 35 (03) : 201 - 210
  • [34] The ethics of placebo-controlled trials - Reply
    Emanuel, EJ
    Miller, FG
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05): : 383 - 383
  • [35] Looking beyond Placebo-Controlled Trials
    Flohr, Carsten
    Weidinger, Stephan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (06) : 1366 - 1367
  • [36] Ethical issues of placebo-controlled trials
    Ferdman, RM
    Church, JA
    JOURNAL OF PEDIATRICS, 1999, 134 (02): : 251 - 251
  • [37] Ethics and science of placebo-controlled trials
    Healy, D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (06) : 598 - 599
  • [38] Control Theory: Placebo-Controlled Drug Trials Have Problems. Active-Controlled Drug Trials Are Not Always the Solution
    Golomb, Beatrice Alexandra
    AMERICAN JOURNAL OF BIOETHICS, 2009, 9 (09): : 67 - 69
  • [39] Placebo-To be or not to be? Are there really alternatives to placebo-controlled trials?
    Krol, Fas Jacob
    Hagin, Michal
    Vieta, Eduard
    Harazi, Rephael
    Lotan, Amit
    Strous, Rael D.
    Lerer, Bernard
    Popovic, Dina
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 32 : 1 - 11
  • [40] US Food and Drug Administration and Representation of Older Adults in Clinical Trials
    Lowy, Naomi
    Whyte, John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1706 - U263
12345